Sandoz Group AG (MEX:SDZN) OCF Margin %: 18.18% (As of Dec. 2025) — 87% Above Median


MEX:SDZN Sandoz Group AG MEX:SDZN
16 GF Score
Price MXN1,481.70
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG OCF Margin %?

Sandoz Group AG MEX:SDZN 16 OCF Margin % is 18.18% as of Dec. 2025, which is 87% above its 10-year median of 9.73. GuruFocus rates MEX:SDZN with a GF Score™ of 16/100. The stock has 6 warning signs investors should review. Among 959 Drug Manufacturers companies, Sandoz Group AG ranks better than 63.71% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Sandoz Group AG's Cash Flow from Operations for the six months ended in Dec. 2025 was MXN19,284 Mil. Sandoz Group AG's Revenue for the six months ended in Dec. 2025 was MXN106,090 Mil. Therefore, Sandoz Group AG's OCF Margin % for the quarter that ended in Dec. 2025 was 18.18%.

As of today, Sandoz Group AG's current OCF Yield % is 4.35%.

The historical rank and industry rank for Sandoz Group AG's OCF Margin % or its related term are showing as below:

MEX:SDZN' s OCF Margin % Range Over the Past 10 Years
Min: 3.63   Med: 9.73   Max: 14.29
Current: 14.18


During the past 4 years, the highest OCF Margin % of Sandoz Group AG was 14.29%. The lowest was 3.63%. And the median was 9.73%.

MEX:SDZN's OCF Margin % is ranked better than
63.71% of 959 companies
in the Drug Manufacturers industry
Industry Median: 9.94 vs MEX:SDZN: 14.18


Sandoz Group AG OCF Margin % Related Terms


Sandoz Group AG OCF Margin % Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG OCF Margin % Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
OCF Margin %
13.14 3.63 6.32 14.29

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial 5.49 4.52 8.02 9.93 18.18

MEX:SDZN vs ZTS, UTHR, VTRS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sandoz Group AG OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's OCF Margin % falls into.


MEX:SDZN
16GF Score
Sandoz Group AG MEX:SDZN
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Sandoz Group AG's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=28701.086/200889.595
=14.29 %

Sandoz Group AG's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=19284.105/106089.584
=18.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 18.18% mean?
Sandoz Group AG (MEX:SDZN) has a OCF Margin % of 18.18% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sandoz Group AG and its competitors. This is 87% above median its historical median of 9.73. Over the past decade, Sandoz Group AG's OCF Margin % has ranged from 3.63 to 14.29. According to the industry distribution chart, Sandoz Group AG ranks #348 out of 959 companies in the Drug Manufacturers industry, placing it in the top 36.3%.
Is Sandoz Group AG's OCF Margin % too high?
Sandoz Group AG's current OCF Margin % of 18.18% is 87% above median its 10-year median of 9.73. Over the past 10 years, this metric has ranged from a low of 3.63 to a high of 14.29. The Drug Manufacturers industry median OCF Margin % is 9.94. Sandoz Group AG's value of 18.18% is 82.9% above this industry median. Based on the distribution chart, Sandoz Group AG ranks #348 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sandoz Group AG has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sandoz Group AG ranks #348 out of 959 companies for OCF Margin %. This puts Sandoz Group AG in the upper half of its industry. The industry median OCF Margin % is 9.94. Sandoz Group AG's value of 18.18% is 82.9% above this benchmark. Historically, Sandoz Group AG's own OCF Margin % has ranged from 3.63 to 14.29 over the past decade. While the company's 10-year median is 9.73 vs. the industry median of 9.94, Sandoz Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sandoz Group AG's current OCF Margin % of 18.18% is 82.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sandoz Group AG and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sandoz Group AG's current OCF Margin % is 18.18%, which is 87% above median its own 10-year median of 9.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (MEX:SDZN) has a current OCF Margin % of 18.18%. The current OCF Margin % is 18.18%, which is 87% above median its 10-year median of 9.73 and 82.9% above the Drug Manufacturers industry median of 9.94. Sandoz Group AG's overall GF Score™ is 16/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sandoz Group AG (MEX:SDZN), the current OCF Margin % is 18.18% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
16GF Score

Get the complete analysis for MEX:SDZN

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,481.70
Price